We´re looking for partners for developing new lines of clinical research based on antibody technology such as nanotechnology applied to flow cytometry. Our aim is improving current methods with poor results detected on blood samples, in relevant issues for clinical diagnosis and monitoring.

We´re also interested in collaborations based in improving of in situ hybridization probes by initiating a combined study of different types of complementary RNA and DNA probes that allow us a combined probes system for monitoring disease into a single test.